BACKGROUND: Magnesium sulfate is neuroprotective in preclinical models of stroke and has shown signals of potential efficacy with an acceptable safety profile when delivered early after stroke onset in humans. Delayed initiation of neuroprotective agents has hindered earlier phase 3 trials of neurop...
Research Assistant
AI chat, annotations, notes & similar papers
No comments yet
Be the first to share your thoughts!